OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harnessing Allostery: A Novel Approach to Drug Discovery
Shaoyong Lu, Shuai Li, Jian Zhang
Medicinal Research Reviews (2014) Vol. 34, Iss. 6, pp. 1242-1285
Closed Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Akt in cancer: Mediator and more
Sundaramoorthy Revathidevi, Arasambattu Kannan Munirajan
Seminars in Cancer Biology (2019) Vol. 59, pp. 80-91
Closed Access | Times Cited: 562

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
George Mihai Niţulescu, Denisa Margină, Petras Juzenas, et al.
International Journal of Oncology (2015) Vol. 48, Iss. 3, pp. 869-885
Open Access | Times Cited: 341

Ras Conformational Ensembles, Allostery, and Signaling
Shaoyong Lu, Hyunbum Jang, Serena Muratcioğlu, et al.
Chemical Reviews (2016) Vol. 116, Iss. 11, pp. 6607-6665
Closed Access | Times Cited: 325

Dynamics-Driven Allostery in Protein Kinases
Alexandr P. Kornev, Susan S. Taylor
Trends in Biochemical Sciences (2015) Vol. 40, Iss. 11, pp. 628-647
Open Access | Times Cited: 266

The Role of mTOR Signaling as a Therapeutic Target in Cancer
N. V. Popova, Manfred Jücker
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1743-1743
Open Access | Times Cited: 194

The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B
Shaoyong Lu, Hyunbum Jang, Ruth Nussinov, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 187

Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Shaoyong Lu, Hyunbum Jang, Shuo Gu, et al.
Chemical Society Reviews (2016) Vol. 45, Iss. 18, pp. 4929-4952
Open Access | Times Cited: 174

Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design
Shaoyong Lu, Xinheng He, Zhao Yang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 166

Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products
Iksen Iksen, Sutthaorn Pothongsrisit, Varisa Pongrakhananon
Molecules (2021) Vol. 26, Iss. 13, pp. 4100-4100
Open Access | Times Cited: 161

Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu, Xinheng He, Duan Ni, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 14, pp. 6405-6421
Closed Access | Times Cited: 149

Protein contact network topology: a natural language for allostery
Luisa Di Paola, Alessandro Giuliani
Current Opinion in Structural Biology (2015) Vol. 31, pp. 43-48
Closed Access | Times Cited: 158

Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms
Shaoyong Lu, Qiancheng Shen, Jian Zhang
Accounts of Chemical Research (2019) Vol. 52, Iss. 2, pp. 492-500
Closed Access | Times Cited: 140

Allosteric sites: remote control in regulation of protein activity
Enrico Guarnera, Igor N. Berezovsky
Current Opinion in Structural Biology (2015) Vol. 37, pp. 1-8
Closed Access | Times Cited: 130

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions
Shaoyong Lu, Jian Zhang
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 24-45
Closed Access | Times Cited: 128

The past, present and future perspectives of matrix metalloproteinase inhibitors
Kang Li, Franklin R. Tay, Cynthia Kar Yung Yiu
Pharmacology & Therapeutics (2019) Vol. 207, pp. 107465-107465
Closed Access | Times Cited: 128

ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks
Qiancheng Shen, Guanqiao Wang, Shuai Li, et al.
Nucleic Acids Research (2015) Vol. 44, Iss. D1, pp. D527-D535
Open Access | Times Cited: 121

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, et al.
PLoS Computational Biology (2019) Vol. 15, Iss. 3, pp. e1006658-e1006658
Open Access | Times Cited: 119

Improved Method for the Identification and Validation of Allosteric Sites
Kun Song, Xinyi Liu, Wenkang Huang, et al.
Journal of Chemical Information and Modeling (2017) Vol. 57, Iss. 9, pp. 2358-2363
Closed Access | Times Cited: 117

Discovery of hidden allosteric sites as novel targets for allosteric drug design
Shaoyong Lu, Mingfei Ji, Duan Ni, et al.
Drug Discovery Today (2017) Vol. 23, Iss. 2, pp. 359-365
Closed Access | Times Cited: 104

ASBench: benchmarking sets for allosteric discovery
Wenkang Huang, Guanqiao Wang, Qiancheng Shen, et al.
Bioinformatics (2015) Vol. 31, Iss. 15, pp. 2598-2600
Open Access | Times Cited: 97

A Chemical Perspective on Allostery
André A. S. T. Ribeiro, Vanessa Ortiz
Chemical Reviews (2016) Vol. 116, Iss. 11, pp. 6488-6502
Closed Access | Times Cited: 97

Recent computational advances in the identification of allosteric sites in proteins
Shaoyong Lu, Wenkang Huang, Jian Zhang
Drug Discovery Today (2014) Vol. 19, Iss. 10, pp. 1595-1600
Closed Access | Times Cited: 96

Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery
Duan Ni, Shaoyong Lu, Jian Zhang
Medicinal Research Reviews (2019) Vol. 39, Iss. 6, pp. 2314-2342
Closed Access | Times Cited: 90

Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery
Shaoyong Lu, Yuran Qiu, Duan Ni, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 1, pp. 177-184
Closed Access | Times Cited: 79

Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance
Duan Ni, Yun Li, Yuran Qiu, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 5, pp. 336-348
Closed Access | Times Cited: 73

Page 1 - Next Page

Scroll to top